EVO:NASDAQ
Evotec SE
$1.68
arrow_downward
-0.59%(-0.010) 1D
Nov 12, 1:12:29 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVO...
Open
$1.65
High
$1.69
Low
$1.64
Mkt. cap
624.00M
Avg. vol.
100.88K
Volume
31.66K
52-wk high
$3.87
52-wk low
$1.33
EPS
-$0.56
Beta
2.02
Shares outstanding
355.82M
No. of employees
4K
Open
$1.65
High
$1.69
Low
$1.64
Mkt. cap
624.00M
Avg. vol.
100.88K
Volume
31.66K
52-wk high
$3.87
52-wk low
$1.33
EPS
-$0.56
Beta
2.02
Shares outstanding
355.82M
No. of employees
4K
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Top Movers: Gainers and Losers on Nov. 12, 2026
24/7 Wall St.
·
14 minutes ago
Even After a 5% Dividend Raise, UnitedHealth Has Left $1,000 From Ten Years Ago at $2,993 While the S&P 500 Topped $4,000
Barron's
·
22 minutes ago
You Don’t Need Nvidia to Beat the S&P 500. These ETFs Prove It.
The Motley Fool
·
13 minutes ago
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE